CTMX vs CMDB
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
CTMX · CytomX$2.03 ▼ 0.98%
CMDB · Costamare Bulkers Holdings$18.19 ▼ 2.47%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- CTMX -48.9%
- CMDB +5.5%
Head to head
| Metric | CTMX | CMDB |
|---|---|---|
| Price | $2.03 | $18.19 |
| Change today | ▼ 0.98% | ▼ 2.47% |
| Market cap | $442.55M | $442.04M |
| Return, 3 months | -38.3% | -10.0% |
| Return, year to date | -52.3% | +18.0% |
| Return, 1 year | -47.7% | +16.4% |
| P/E (TTM) | – | 43.3 |
| P/B | 1.6 | 0.6 |
| P/E percentile vs own 5y | 25th | 81st |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -71.7% | -41.0% |
| Net profit growth (YoY) | -40.5% | +124.3% |
| Gross margin | – | 20.9% |
| Operating margin | -676.4% | 3.1% |
| Net margin | -608.9% | 2.4% |
| Return on equity | -43.6% | 2.0% |
| Analyst target vs. price | +540.4% | – |
| Analyst buy share | 100% | – |
| RSI (14) | 42 | 38 |
| 30-day volatility | 80.5% | 37.7% |
| Max drawdown, 1 year | -72.1% | -27.4% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- CTMX is the largest of the group by market value.
- CMDB has returned the most over the past year.
- CMDB is growing revenue fastest.
- CMDB keeps the most profit per dollar of sales.
- CMDB has been the calmest stock over the last 30 days.